Dec 2, 2014
Antabio announces that it will receive EUR 90,000 in funding from the Midi-Pyrénées Region to support the expansion of its R&D capabilities in Labège. This funding will be awarded to Antabio under the Innovative SMEs Support Contracts scheme (“Contrat d’Appui PME...
Jun 2, 2014
Antabio’s profile is featured in a double-page article of the June 2014 special issue on infectious diseases of Nature Biopharma Dealmakers.The article describes the company’s history since its inception featuring some of its most innovative achievements, including...
Feb 27, 2014
Antabio announced today that it has identified a lead series of pan-metallo beta-lactamase inhibitors that, in combination with carbapenems, restores antibacterial activity against life-threatening clinical isolates whilst exhibiting no toxicity or developmental...
Jan 31, 2013
Harlow, UK and Labège, France – Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has signed a collaboration agreement with Antabio. Under the terms of the...
Jul 4, 2011
Antabio receives a grant from Oséo, the French public institution responsible for supporting innovation and growth of SME’s in France, to support its new discovery programme.
Mar 30, 2010
BioMedicalAlliance is a not for profit organization supporting the biopharma industry in the Midi-Pyrenees region (France).
